Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

NCT05806164 is registered in ClinicalTrials.gov with Women and Infants Hospital of Rhode Island as lead sponsor.

NCT NCT05806164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05806164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Lead sponsor
Women and Infants Hospital of Rhode Island
Phase
Phase 4
Overall status
Active, not recruiting
Start date
June 6, 2023
Completion date
August 1, 2030
Enrollment
432 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

urgency urinary incontinence